Clinical activity of celecoxib in metastatic malignant melanoma.

about

A large cohort study of nonsteroidal anti-inflammatory drug use and melanoma incidence.

P2860

Q36922601-DAF52BDE-E7D0-4586-B839-922EF1B40FEE

P2860

Clinical activity of celecoxib in metastatic malignant melanoma.

Item

http://www.wikidata.org/entity/Q45076856

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年学术文章

@wuu

2006年学术文章

@zh

2006年学术文章

@zh-cn

2006年学术文章

@zh-hans

2006年学术文章

@zh-my

2006年学术文章

@zh-sg

2006年學術文章

@yue

2006年學術文章

@zh-hant

name

Clinical activity of celecoxib in metastatic malignant melanoma.

@en

Clinical activity of celecoxib in metastatic malignant melanoma.

@nl

type

Item

label

Clinical activity of celecoxib in metastatic malignant melanoma.

@en

Clinical activity of celecoxib in metastatic malignant melanoma.

@nl

prefLabel

Clinical activity of celecoxib in metastatic malignant melanoma.

@en

Clinical activity of celecoxib in metastatic malignant melanoma.

@nl

P1476

Clinical activity of celecoxib in metastatic malignant melanoma.

@en

P2093

Kenneth S Wilson

http://www.w3.org/2001/XMLSchema#string

P2860

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

Randomized phase III study of temozolomide versus dacarbazine in the treatment of patients with advanced metastatic malignant melanoma

IL-1 is required for tumor invasiveness and angiogenesis

Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma.

COX-2 inhibitors in cancer treatment and prevention, a recent development.

Transcriptional regulation of cyclooxygenase-2 in the human microvascular endothelial cell line, HMEC-1: control by the combinatorial actions of AP2, NF-IL-6 and CRE elements.

Cyclooxygenase-2, player or spectator in cyclooxygenase-2 inhibitor-induced apoptosis in prostate cancer cells.

Progression and NSAID-induced apoptosis in malignant melanomas are independent of cyclooxygenase II.

Role of mitogen-activated protein kinase cascades in mediating lipopolysaccharide-stimulated induction of cyclooxygenase-2 and IL-1 beta in RAW264 macrophages.

Treatment of uveal melanoma metastatic to the liver: a review of the M. D. Anderson Cancer Center experience and prognostic factors.

P304

740-746

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/07357900601063790

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2006-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6636392

http://www.w3.org/2001/XMLSchema#string

P698

17162556

http://www.w3.org/2001/XMLSchema#string

Clinical activity of celecoxib in metastatic malignant melanoma.

about

P2860

P2860

Clinical activity of celecoxib in metastatic malignant melanoma.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698